Nephrocare Health Services Limited (NSE:NEPHROPLUS)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Providing Dialysis and Related Healthcare Services	9.99B	7.56B	5.66B	4.37B	3.17B
Providing Dialysis and Related Healthcare Services Growth	32.16%	33.50%	29.47%	37.99%	11.40%
Total	9.99B	7.56B	5.66B	4.37B	3.17B
Total Growth	32.16%	33.50%	29.47%	37.99%	11.40%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
India	5.81B	5.16B	4.32B	3.86B	3.17B
India Growth	12.77%	19.46%	11.77%	21.84%	11.40%
outside India	4.18B	-	-	-	-
Uzbekistan	-	733.95M	664.95M	168.50M	-
Uzbekistan Growth	-	10.38%	294.63%	-	-
Philippines	-	1.67B	681.21M	343.34M	-
Philippines Growth	-	144.48%	98.41%	-	-
Others	-	3.71M	-	-	-
Total	9.99B	7.56B	5.66B	4.37B	3.17B
Total Growth	32.16%	33.50%	29.47%	37.99%	11.40%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error